Close

Life on
your terms.

Knowledge is
reproductive power.

Prelude, a leader in reproductive science and technology, helps people have healthy babies when they’re ready. Whether you’re just getting started in life or have been at it awhile, if you’re not ready today but might be someday, if the family you want is different than the family you came from, you now have options.

As more people delay childbirth into their 30s and 40s to complete their education, pursue their dream job, or find their soulmate, reproductive clarity becomes more and more important. The Prelude Method is designed to give you the most reproductive choices and control over your biological clock.

 

The Prelude Method,
explained.

1. Fertility Preservation

Women’s eggs and men’s sperm are frozen during their peak fertility years—20s and early 30s. Contrary to popular belief, it’s not just women’s eggs that carry risks associated with declining fertility. Advancing paternal age also has been associated with higher incidence in offspring of illnesses such as autism and bipolar disorder.

2. Embryo Creation

When ready to start a family, eggs and sperm are unfrozen and combined to create embryos.
 

3. Genetic Screening

Before the embryo is implanted, parents are screened for common inherited diseases. If parental testing reveals risks, the embryos are tested for genetic diseases. Embryos are also tested for chromosomal abnormalities. As genetic screening improves, the number of illnesses that can be detected will rise over time, and so will the chances of having a healthy baby.

4. Single Embryo Transfer

An embryo is selected that will maximize the likelihood of a healthy birth.

By coupling earlier decision making with the latest reproductive science and technology, The Prelude Method can dramatically increase the probability of having a healthy baby and decrease the chances of requiring infertility therapy later in life.

Leaders in Reproductive Science and Technology

Reproductive Biology Associates (RBA), a Prelude company, is the oldest continuously operating full-service private fertility treatment center in the United States. Based in Atlanta, Georgia, and founded in 1983, RBA has led the development, improvement, and application of clinical and applied sciences to improve fertility care. It has also been responsible for several notable “firsts” in reproductive medicine.

The Nation’s Largest
Frozen Donor Egg Bank

My Egg Bank North America, a Prelude company, offers the proprietary cryogenic egg vitrification process originally developed by Reproductive Biology Associates, across a national network of fertility clinics.

The Team
Martin Varsavsky
Founder, Chairman, and CEO—Martin Varsavsky is a serial tech entrepreneur committed to bringing advances in science and technology to society that create meaningful social impact and improve people’s lives. The story of his and his wife’s personal fertility journey is the genesis and foundation of Prelude.
Joanna Rees
Board Member—Joanna Rees is a managing partner at West. She has served on the board of more than 25 public or venture-backed companies across a broad range of industry sectors. She is a Senior Partner at the B Team and serves on the boards of Endeavor Global and Build National.
Geoff Crouse
Board Member—Geoff Crouse is a senior executive with extensive experience building successful companies in both life sciences and consumer healthcare, and is supporting the launch of Prelude as the interim President. Geoff most recently was the CEO of Cord Blood Registry, the world’s largest private cord blood and tissue bank.
Dr. Daniel Shapiro
Dr. Shapiro is a Reproductive Endocrinologist and Chief Medical Officer at RBA and co-founder of My Egg Bank North America, the first multi-center network of fertility centers offering cryogenic egg vitrification.
Dr. Andrew Toledo
Dr. Toledo is a Reproductive Endocrinologist and Fertility Specialist and CEO of RBA. A thought leader in reproductive medicine, his focus is on advanced reproductive technologies, reproductive surgery, and recurrent pregnancy loss.
Dr. Zsolt Peter Nagy
Dr. Nagy is a world-renowned Embryologist and Fertility Specialist and co-creator of a novel vitrification protocol (flash-freezing technology). Dr. Nagy was also part of the team that developed a novel insemination procedure, intracytoplasmic sperm injection.
Dr. Mehmet Oz
Dr. Oz is Professor of Surgery at New York Presbyterian/Columbia University and directs the Integrative Medicine service. His research interests include heart replacement surgery, minimally invasive surgery, and healthcare policy. He has authored over 400 original publications, book chapters, and medical books; has performed more than 5,000 heart surgeries in his career and has received eight patents. He launched his syndicated talk show seven years ago and has won seven Daytime Emmy Awards.
Tia Newcomer
Tia Newcomer, Chief Revenue Officer, is a senior consumer goods executive with extensive experience marketing to millennials and women. Prior to joining Prelude, Newcomer most recently served as the Vice President of Commercial Operations and Marketing at Cord Blood Registry (CBR), the world’s largest private cord blood and tissue bank.
Dr. Michael Witt
Dr. Witt is RBA’s in-house, board-certified urologist, specializing in the diagnosis and personalized treatment of male factor infertility. Dr. Witt has published over 20 articles in medical journals and written numerous medical text chapters on the treatment of male infertility.
Jamie Dokson
Jamie Dokson is RBA’s Director of Genetic Services and a board-certified genetic counselor, licensed in 10 states, with clinical experience and significant expertise in reproductive and prenatal genetics.